CVS and Aetna merger a disruptive sign of the future
The proposed CVS Health-Aetna merger is emblematic of the growing arms race to consolidate and control consumer access to appropriate prescription drugs, particularly LTC (long-term care) patients…Read More.
To protect seniors, Congress should adopt clear, statutory definition of long term care pharmacies
When it comes to the “alphabet soup” of federal agencies, one’s eyes can glaze over in confusion and uncertainty about what they do, why they do it, and how average citizens benefit from their federally-funded oversight…Read More.
Rosenbloom: No More Exploitation of Seniors, Taxpayers by PBMs
Pharmacy benefit managers have long enough taken advantage seniors and taxpayers in the U.S. through strategies that exploit Medicare, Senior Care Pharmacy Coalition President/CEO Alan Rosenbloom writes…Read More.
PBMs must stop taking advantage of seniors and taxpayers
As much as we can appreciate the ingenuity of entrepreneurs in a free market, programs like Medicare were never intended to pad the pockets of businesses at the expense of consumers and taxpayers…Read More.
Brady Says Drug Rebates Should Be Shared With Seniors, But It’s Not Clear How
Inside Health Policy
House Ways & Means Chair Kevin Brady (R-TX) relayed to HHS Secretary Alex Azar Thursday (Sept. 6) his reservations with making health plans share drug rebates at the point of sale…Read More.
To Help Seniors Served by LTC Pharmacies, DIR Fees Should Simply be Prohibited
Tired of being kept in the dark about the mysterious prescription drug cost pricing process, Congress has proposed a variety of bipartisan legislative reforms designed to shed light on a system seemingly designed at the outset to confuse, befuddle and bewilder…Read More.
Medicare Part D premiums down, CMS says, as administration aims to curtail swelling drug costs
Premiums for nursing home residents’ prescription drug plans have dipped for the second year in a row, in what the administration hopes is a sign that efforts to curb prescription costs might be taking hold…Read More.
It’s Generics Not PBMs That Keep Pharmaceuticals Affordable
Expenditures on prescription drugs grew 12.4 percent in 2014 and 8.9 percent in 2015. These eye-popping data are not representative of the long-term expenditure trend, however…Read More.